John E. Morley, M.D.
During the last three years, Dr. Morley has received grant/research support from Vivus, Merck & Co., Upjohn, B. Braun McGaw, Bayer Corp and Nestec, Ltd. He has also served on the Speakers' Bureau for LXN, Organon, Ross, Pharmacia & Upjohn, Glaxo Wellcome, Hoechst Marion Roussel, Searle, Merck & Co., Roche, Bristol-Myers Squibb, Novartis, Pratt, B. Braun McGaw, Pfizer and Parke-Davis.
This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.
Release Date: 05/07/2002
Upon completion of this Cyberounds®, you should be able to:
Recognize the significance of benign cognitive dysfunction
Discuss the possible role of homocysteine in dementia
Manage the non-cognitive behavioral problems of dementia.